keyword
MENU ▼
Read by QxMD icon Read
search

Edta chelation therapy

keyword
https://www.readbyqxmd.com/read/27915165/re-assessing-gallium-67-as-a-therapeutic-radionuclide
#1
Muhamad F Bin Othman, Nabil R Mitry, Valerie J Lewington, Philip J Blower, Samantha Y A Terry
INTRODUCTION: Despite its desirable half-life and low energy Auger electrons that travel further than for other radionuclides, (67)Ga has been neglected as a therapeutic radionuclide. Here, (67)Ga is compared with Auger electron emitter (111)In as a potential therapeutic radionuclide. METHODS: Plasmid pBR322 studies allowed direct comparison between (67)Ga and (111)In (1MBq) in causing DNA damage, including the effect of chelators (EDTA and DTPA) and the effects of a free radical scavenger (DMSO)...
October 29, 2016: Nuclear Medicine and Biology
https://www.readbyqxmd.com/read/27896275/rationale-for-the-successful-management-of-edta-chelation-therapy-in-human-burden-by-toxic-metals
#2
REVIEW
Maria Elena Ferrero
Exposure to environmental and occupational toxicants is responsible for adverse effects on human health. Chelation therapy is the only procedure able to remove toxic metals from human organs and tissue, aiming to treat damage related to acute and/or chronic intoxication. The present review focuses on the most recent evidence of the successful use of the chelating agent ethylenediaminetetraacetic acid (EDTA). Assessment of toxic-metal presence in humans, as well as the rationale of EDTA therapy in cardiovascular and neurodegenerative diseases, is reported...
2016: BioMed Research International
https://www.readbyqxmd.com/read/27698934/reversal-of-vascular-calcification-and-aneurysms-in-a-rat-model-using-dual-targeted-therapy-with-edta-and-pgg-loaded-nanoparticles
#3
Nasim Nosoudi, Aniqa Chowdhury, Steven Siclari, Saketh Karamched, Vaideesh Parasaram, Joe Parrish, Patrick Gerard, Narendra Vyavahare
Degeneration of elastic lamina and vascular calcification are common features of vascular pathology such as aortic aneurysms. We tested whether dual therapy with targeted nanoparticles (NPs) can remove mineral deposits (by delivery of a chelating agent, ethylene diamine tetraacetic acid (EDTA)) and restore elastic lamina (by delivery of a polyphenol, pentagalloyl glucose (PGG)) to reverse moderate aneurysm development. EDTA followed by PGG NP delivery led to reduction in macrophage recruitment, matrix metalloproteinase (MMP) activity, elastin degradation and calcification in the aorta as compared to delivery of control blank NPs...
2016: Theranostics
https://www.readbyqxmd.com/read/27163837/massive-intravenous-manganese-overdose-due-to-compounding-error-minimal-role-for-hemodialysis
#4
Elizabeth Quaal Hines, Irfana Soomro, Mary Ann Howland, Robert S Hoffman, Silas W Smith
CONTEXT: Manganese-associated parkinsonism is well described in occupational settings, in chronic methcathinone users, and in patients receiving long-term total parenteral nutrition. We present a unique case of acute intravenous manganese poisoning with a systematic evaluation of hemodialysis efficacy. CASE DETAILS: A 52-year-old woman was inadvertently administered a single intravenous dose of 800 mg compounded manganese chloride at an outpatient chelation center...
July 2016: Clinical Toxicology
https://www.readbyqxmd.com/read/27148463/n-acetyl-cysteine-as-effective-and-safe-chelating-agent-in-metal-on-metal-hip-implanted-patients-two-cases
#5
Andrea Giampreti, Davide Lonati, Benedetta Ragghianti, Anna Ronchi, Valeria Margherita Petrolini, Sarah Vecchio, Carlo Alessandro Locatelli
Systemic toxicity associated with cobalt (Co) and chromium (Cr) containing metal hip alloy may result in neuropathy, cardiomyopathy, and hypothyroidism. However clinical management concerning chelating therapy is still debated in literature. Here are described two metal-on-metal hip-implanted patients in which N-acetyl-cysteine decreased elevated blood metal levels. A 67-year-old male who underwent Co/Cr hip implant in September 2009 referred to our Poison Control Centre for persisting elevated Co/Cr blood levels (from March 2012 to November 2014)...
2016: Case Reports in Orthopedics
https://www.readbyqxmd.com/read/26933485/severe-abdominal-pain-caused-by-lead-toxicity-without-response-to-oral-chelators-a-case-report
#6
Hassan Vossoughinia, Ali Pourakbar, Samaneh Esfandiari, Masoud Sharifianrazavi
A 19-year-old woman was referred to the Emergency Surgery Department with severe abdominal pain, icterus, and anemia. The patient's clinical and paraclinical findings in addition to her occupational and social history, convinced us to assay blood lead level (BLL), which was 41/5 μg/dL. Therefore toxicology consult was performed to treat lead toxicity. Recheck of the BLL showed the level as 53/7 μg/dL. So oral chelator with succimer was started. Despite consumption of oral chelator, there was no response and the pain continued...
January 2016: Middle East Journal of Digestive Diseases
https://www.readbyqxmd.com/read/26892121/chelation-therapy-in-the-treatment-of-cardiovascular-diseases
#7
REVIEW
Awais Ibad, Rabia Khalid, Paul D Thompson
OBJECTIVE: We examined the effect of chelation therapy on cardiovascular diseases (CVDs). BACKGROUND: EDTA is a chelating agent that binds to metals including calcium and facilitates their excretion. Chelation with EDTA is recommended by some practitioners to treat CVD with the hypothesis that reducing calcium reduces atherosclerotic calcification of arteries. However, chelation therapy has not been approved by the Food and Drug Administration, and its effectiveness is unclear...
January 2016: Journal of Clinical Lipidology
https://www.readbyqxmd.com/read/26594027/enteric-coated-tablet-of-risedronate-sodium-in-combination-with-phytic-acid-a-natural-chelating-agent-for-improved-oral-bioavailability
#8
Jeong S Kim, Sun W Jang, Miwon Son, Byoung M Kim, Myung J Kang
The oral bioavailability (BA) of risedronate sodium (RS), an antiresorptive agent, is less than 1% due to its low membrane permeability as well as the formation of non-absorbable complexes with multivalent cations such as calcium ion (Ca(2+)) in the gastrointestinal tract. In the present study, to increase oral BA of the bisphosphonate, a novel enteric-coated tablet (ECT) dosage form of RS in combination with phytic acid (IP6), a natural chelating agent recognized as safe, was formulated. The chelating behavior of IP6 against Ca(2+), including a stability constant for complex formulation was characterized using the continuous variation method...
January 20, 2016: European Journal of Pharmaceutical Sciences
https://www.readbyqxmd.com/read/26364188/edta-chelation-therapy-to-reduce-cardiovascular-events-in-persons-with-diabetes
#9
REVIEW
Pamela Ouyang, Sheldon H Gottlieb, Valerie L Culotta, Ana Navas-Acien
The Trial to Assess Chelation Therapy (TACT) was a randomized double-blind placebo-controlled trial enrolling patients age ≥50 years with prior myocardial infarction. TACT used a 2 × 2 factorial design to study ethylene diamine tetraacetic acid (EDTA) chelation and high-dose vitamin supplementation. Chelation provided a modest but significant reduction in cardiovascular endpoints. The benefit was stronger and significant among participants with diabetes but absent in those without diabetes. Mechanisms by which chelation might reduce cardiovascular risk in persons with diabetes include the effects of EDTA chelation on transition and toxic metals...
November 2015: Current Cardiology Reports
https://www.readbyqxmd.com/read/26299078/identification-and-characterization-of-edta-test-strip-interfering-substances-using-a-digital-color-detector
#10
Kelly L Scholes, Ammon T Ence, Frederick G Strathmann, Jonathan R Genzen
BACKGROUND: Rapid test strips for ethylenediaminetetraacetic acid (EDTA) can be used to verify correct specimen types for clinical assays which require, or cannot be performed on, plasma collection tubes containing EDTA anticoagulant. As the test strip reaction chemistry is based on a color change induced by chelation of bismuth from a xylenol orange complex, we hypothesized that any agent capable of chelating bismuth might induce false positive test strip reactivity. The present study was therefore designed to evaluate the potential for test strip interference by chelating agents commonly used in the treatment of trace and heavy metal toxicity...
2015: Clinical Laboratory
https://www.readbyqxmd.com/read/25825603/3d-porous-calcium-alginate-scaffolds-cell-culture-system-improved-human-osteoblast-cell-clusters-for-cell-therapy
#11
Ching-Yun Chen, Cherng-Jyh Ke, Ko-Chung Yen, Hui-Chen Hsieh, Jui-Sheng Sun, Feng-Huei Lin
Age-related orthopedic disorders and bone defects have become a critical public health issue, and cell-based therapy is potentially a novel solution for issues surrounding bone tissue engineering and regenerative medicine. Long-term cultures of primary bone cells exhibit phenotypic and functional degeneration; therefore, culturing cells or tissues suitable for clinical use remain a challenge. A platform consisting of human osteoblasts (hOBs), calcium-alginate (Ca-Alginate) scaffolds, and a self-made bioreactor system was established for autologous transplantation of human osteoblast cell clusters...
2015: Theranostics
https://www.readbyqxmd.com/read/25727711/removal-of-iron-by-chelation-with-molecularly-imprinted-supermacroporous-cryogel
#12
Duygu Çimen, Ilgım Göktürk, Fatma Yılmaz
Iron chelation therapy can be used for the selective removal of Fe(3+) ions from spiked human plasma by ion imprinting. N-Methacryloyl-(L)-glutamic acid (MAGA) was chosen as the chelating monomer. In the first step, MAGA was complexed with the Fe(3+) ions to prepare the precomplex, and then the ion-imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-(L)-glutamic acid) [PHEMAGA-Fe(3+)] cryogel column was prepared by cryo-polymerization under a semi-frozen temperature of - 12°C for 24 h. Subsequently, the template, of Fe(3+) ions was removed from the matrix by using 0...
June 2016: Artificial Cells, Nanomedicine, and Biotechnology
https://www.readbyqxmd.com/read/25712314/in-vitro-activity-of-gentamicin-vancomycin-or-amikacin-combined-with-edta-or-l-arginine-as-lock-therapy-against-a-wide-spectrum-of-biofilm-forming-clinical-strains-isolated-from-catheter-related-infections
#13
David Lebeaux, Véronique Leflon-Guibout, Jean-Marc Ghigo, Christophe Beloin
OBJECTIVES: Treatment of catheter-related bloodstream infections (CRBSI) is hampered by the characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study the effect of the combination of antibiotics and the alkaline amino acid l-arginine or the cation chelator EDTA on the bacterial killing of in vitro biofilms formed by an array of clinical strains responsible for CRBSI and representative of epidemiologically relevant bacterial species. METHODS: Among 32 strains described in a previous clinical study, we focused on the most antibiotic-tolerant strains including CoNS (n = 4), Staphylococcus aureus (n = 4), Enterococcus faecalis (n = 2), Pseudomonas aeruginosa (n = 4) and Enterobacteriaceae (n = 4)...
2015: Journal of Antimicrobial Chemotherapy
https://www.readbyqxmd.com/read/25635662/interplay-between-inhibitory-ferric-and-stimulatory-curcumin-regulates-phosphorylation-dependent-human-cystic-fibrosis-transmembrane-conductance-regulator-and-%C3%AE-f508-activity
#14
Guangyu Wang
Curcumin potentiates cystic fibrosis transmembrane conductance regulator (CFTR) activation in an ATP-independent but phosphorylation-dependent manner. The underlying molecular mechanisms are unclear. Here, HEK-293T cells cultured in an Fe(3+)-containing medium were transiently transfected with CFTR constructs, and the role of the inhibitory Fe(3+) bridge between intracellular loop 3 and the regulatory domain of CFTR in this pathway was investigated. The results showed that ethylenediaminetetraacetic acid (EDTA) stimulated phosphorylation-dependent CFTR activation and the stimulation was suppressed by the deletion of the regulatory domain or the insertion of a C832A mutation that removes the Fe(3+)-binding interface...
February 24, 2015: Biochemistry
https://www.readbyqxmd.com/read/25625077/an-in-vitro-evaluation-of-the-effect-of-dentin-deproteinization-on-coronal-microleakage-in-endodontically-treated-teeth
#15
K Vikram Shetty, Kapil Jhajharia, Vishwajit Rampratap Chaurasia, Ashu Jhamb, Varsha Rohra, Akanksha Manmohan Sharma
BACKGROUND: The most common cause of failure of endodontic therapy is inadequate apical and coronal seal. Proper coronal seal reduces the risk of endodontic failure. Hence, the present study was done to test the role of self-etching primers in reducing microleakage through coronal seal. MATERIALS AND METHODS: Following root canal preparation and obturation, 46 specimen teeth were subjected to one of the test methods as follows: Group I - deproteinization with 3% sodium hypochlorite and etching with 37% phosphoric acid; Group II - deproteinization with 3% sodium hypochlorite and chelation with 15% ethylenediaminetetraacetic acid (EDTA) (Glyde) without etching...
December 2014: Journal of International Society of Preventive & Community Dentistry
https://www.readbyqxmd.com/read/25285609/targeted-chelation-therapy-with-edta-loaded-albumin-nanoparticles-regresses-arterial-calcification-without-causing-systemic-side-effects
#16
Yang Lei, Nasim Nosoudi, Naren Vyavahare
BACKGROUND AND AIMS: Elastin-specific medial arterial calcification (MAC) is an arterial disease commonly referred as Monckeberg's sclerosis. It causes significant arterial stiffness, and as yet, no clinical therapy exists to prevent or reverse it. We developed albumin nanoparticles (NPs) loaded with disodium ethylene diaminetetraacetic acid (EDTA) that were designed to target calcified elastic lamina when administrated by intravenous injection. METHODS AND RESULTS: We optimized NP size, charge, and EDTA-loading efficiency (150-200 nm, zeta potential of -22...
December 28, 2014: Journal of Controlled Release: Official Journal of the Controlled Release Society
https://www.readbyqxmd.com/read/25243176/aluminium-involvement-in-neurotoxicity
#17
Alessandro Fulgenzi, Daniele Vietti, Maria Elena Ferrero
The aetiology of neurodegenerative diseases (ND) seems to involve susceptibility genes and environmental factors. Toxic metals are considered major environmental pollutants. Following our study of a case of multiple sclerosis (MS) improvement due to removal of aluminium (Al) and other toxic metals, we have examined the possible relationship between Al intoxication and ND. We used the slow intravenous treatment with the chelating agent EDTA (calcium disodium ethylene diamine tetraacetic acid) (chelation test) to remove Al and detected it in the urine collected from the patients for 12 hours...
2014: BioMed Research International
https://www.readbyqxmd.com/read/25222024/type-i-collagen-as-an-extracellular-matrix-for-the-in-vitro-growth-of-human-small-intestinal-epithelium
#18
Ziyad Jabaji, Garrett J Brinkley, Hassan A Khalil, Connie M Sears, Nan Ye Lei, Michael Lewis, Matthias Stelzner, Martín G Martín, James C Y Dunn
BACKGROUND: We previously reported in vitro maintenance and proliferation of human small intestinal epithelium using Matrigel, a proprietary basement membrane product. There are concerns over the applicability of Matrigel-based methods for future human therapies. We investigated type I collagen as an alternative for the culture of human intestinal epithelial cells. METHODS: Human small intestine was procured from fresh surgical pathology specimens. Small intestinal crypts were isolated using EDTA chelation...
2014: PloS One
https://www.readbyqxmd.com/read/25120359/the-application-of-edta-in-drug-delivery-systems-doxorubicin-liposomes-loaded-via-nh4edta-gradient
#19
Yanzhi Song, Zhenjun Huang, Yang Song, Qingjing Tian, Xinrong Liu, Zhennan She, Jiao Jiao, Eliza Lu, Yihui Deng
The applications of ethylenediaminetetraacetic acid (EDTA) have been expanded from the treatment of heavy metal poisoning to chelation therapies for atherosclerosis, heart disease, and cancers, in which EDTA reduces morbidity and mortality by chelating toxic metal ions. In this study, EDTA was used in a drug delivery system by adopting an NH4EDTA gradient method to load doxorubicin into liposomes with the goal of increasing therapeutic effects and decreasing drug-related cytotoxicity. The particle size of the optimum NH4EDTA gradient liposomes was 79...
2014: International Journal of Nanomedicine
https://www.readbyqxmd.com/read/25114898/improvement-of-oxidative-and-metabolic-parameters-by-cellfood-administration-in-patients-affected-by-neurodegenerative-diseases-on-chelation-treatment
#20
Alessandro Fulgenzi, Rachele De Giuseppe, Fabrizia Bamonti, Maria Elena Ferrero
OBJECTIVE: This prospective pilot study aimed at evaluating the effects of therapy with antioxidant compounds (Cellfood, and other antioxidants) on patients affected by neurodegenerative diseases (ND), who displayed toxic metal burden and were subjected to chelation treatment with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNa2EDTA or EDTA). METHODS: Two groups of subjects were studied: (a) 39 patients affected by ND and (b) 11 subjects unaffected by ND (controls)...
2014: BioMed Research International
keyword
keyword
96219
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"